The future looks bright for the use of graphene in the mass production of biocompatible sensor devices with the development of a new microfabrication process. [ + ]

AusBiotech's substantive submission to the Senate Standing Committee on Economics' Australian Innovation System inquiry has called for tax reform, support for commercialisation, incentives for commercial thinking and clinical trial reform. [ + ]

Immuron's (ASX:IMC) distribution partner Paladin Labs has launched OTC travellers' diarrhoea treatment Travelan in Canada. [ + ]

A collaboration between the Burnet Institute and ARTES Biotechnology will progress the development of and test a new strategy for a malaria vaccine. [ + ]

Calzada (ASX:CZD) said its peptide AOD9604 has secured Generally Recognised As Safe status in the US, allowing its use in food and supplements at a daily level of up to 1 mg per person. [ + ]

The launch of the Australian Research Council Centre of Excellence in Plant Energy Biology 2014-2020, will focus on understanding and enhancing plant energy systems to increase crop yields. [ + ]

The CSIRO research vessel Investigator is setting sail from Singapore for its new home port of Hobart, where it is expected to arrive by mid-September. The vessel's arrival, which was initially planned for June 2013, will enable the Marine National Facility (MNF) Steering Committee to determine its 2014-15, 2015-16 and 2016-17 voyage scheduling. [ + ]

Healthcare company Baxter International has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to pharmaceutical company Pfizer for a total cash consideration of $635 million, subject to certain adjustments. [ + ]

ResMed (ASX:RMD) has reported a 20% growth in profit but flat revenue for the fourth quarter, and reported the results of a successful study into using NPPH to treat advanced COPD. [ + ]

Who do you think are the industry's high achievers? The annual Industry Excellence Awards celebrate the individuals and organisations that have made a significant contribution to the biotechnology industry and, through their leadership, continue to make a difference to the growth of the bio-economy. The recipients of these prestigious awards are at the forefront of thriving biotech, innovation and healthcare sectors in Australia. [ + ]

US physicians have identified a potential new market for Osprey's AVERT system, which is designed to help protect the kidneys from toxic dyes used in X-ray imaging. [ + ]

QFAB Bioinformatics and the Garvan Institute of Medical Research will combine their capabilities to offer human genome sequence data analysis for scientists and clinicians. [ + ]

Weather Detective, an online citizen science project, is seeking assistance to help uncover important weather records hidden in the log books of ships that sailed the seas around Australia in the 1890s and 1900s. [ + ]

ARTES Biotechnology and the Burnet Institute are collaborating to develop a new type of malaria vaccine in a project funded by the PATH Malaria Vaccine Initiative (MVI). The project will focus on strategies to produce vaccines that can block the transmission of malaria infection from mosquitoes to people. [ + ]

Academics from Trinity College Dublin have shed light on the market dynamics and potential in licensing deals with big pharmaceutical companies. Their findings are of particular relevance to those working in and funding drug development worldwide. [ + ]